Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 539787 | NSE Symbol : HCG | ISIN : INE075I01017 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
12-May-2025	24-May-2025	Accounts	Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2025 inter alia to consider and approve Audited Financial Results (both Standalone and Consolidated) of the Company for the quarter and year ended March 31 2025 (Audited Financial Results). The Board of Directors of the Company at its meeting held on May 24, 2025 has considered and approved the Audited Financial Results (Standalone and Consolidated) for quarter and year ended March 31, 2025. (As Per BSE Announcement Dated on :24.05.2025)
24-Feb-2025	21-Feb-2025	Others	Disclosure under Regulation 30
05-Feb-2025	14-Feb-2025	Quarterly Results	Quarterly Results Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2024 The Board Meeting to be held on 13/02/2025 has been revised to 14/02/2025 The Board Meeting of the Company would commence on Thursday, February 13, 2025 and would continue on Friday, February 14, 2025, and that the Unaudited Financial Results of the Company shall be discussed and considered by the Board on February 14, 2025. (As per BSE Announcement Dated on 11/02/2025) Considered and approved the unaudited financial results of the Company for the quarter and nine months ended Deceber 31, 2024. (As Per BSE Announcement Dated on 14.02.2025)
07-Feb-2025	07-Feb-2025	Change in Directors	Changes in directorship of HealthCare Global Enterprises Limited ('the Company')
24-Oct-2024	09-Nov-2024	Quarterly Results	Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 inter alia to consider and approve and take on record the unaudited financial results for the quarter and six months ended Sept 30 2024. Results-Financial Results for September 30, 2024 (As Per BSE Announcement Dated on: 09/11/2024)
25-Jul-2024	08-Aug-2024	Quarterly Results	Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter ended June 30 2024 ('Unaudited Financial Results'). Unuaudited Financial Results of the Company for the quarter ended June 30, 2024 (As Per BSE Announcement dated on 08.08.2024)
15-May-2024	29-May-2024	Accounts	Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Audited financial results for the year ended March 31 2024 Board of Directors of the Company ('Board'), at their meeting held on this day, May 29, 2024, inter alia, has considered and approved the following agenda: 1. Audited Financial Results (Standalone and Consolidated) of the Company for the year ended March 31, 2024, together with Auditor's Report thereon; 2. Issue and allotment of 28,255 (Twenty-Eight Thousand Two Hundred Fifty Five) equity shares of the Company of INR 10 each, upon exercise of Employee Stock Options in accordance with the existing Employee Stock Option Schemes of the Company. 3. Re-appointment of Ms. Geeta Mathur (DIN: 02139552), as an Independent Director of the Company for a term of three (3) years with effect from June 17, 2024, subject to the approval of shareholders of the Company, and that Ms. Geeta Mathur shall not be liable to retire by rotation. The Company shall make detailed disclosure under Regulation 30 of SEBI LODR Regulations, 2015 in this regard. Pursuant to Regulation 33 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2024, together with Auditor's Report, as approved by the Board. The financial results are also being made available on the Company's website at www.hcgoncology.com We hereby declare that the Statutory Auditors of the Company, M/s. B S R & Co. LLP, have issued an Audit Report with an unmodified opinion on Audited Financial Results (Standalone and Consolidated) of the Company for the year ended March 31, 2024. (As Per BSE Announcement Dated on 29.05.2024)
17-Jan-2024	08-Feb-2024	Quarterly Results	Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and nine months ended December 31 2023 Results - Financial Results for the quarter and nine months ended December 31, 2023. (As per BSE Announcement Dated on 08/02/2024)
25-Oct-2023	09-Nov-2023	Accounts	HEALTHCARE GLOBAL ENTERPRISES LIMITED has informed BSE about Board Meeting to be held on 09 Nov 2023 to consider financial statements for the period ended September 2023. Financial results / Other business / ESOP.
18-Aug-2023	18-Aug-2023	Change in Other Executives	Mr. Srinivasa V Raghavan, CFO and KMP of the Company, will cease to hold the position as the CFO and KMP effective from August 20, 2023, on account of his retirement from the Company. Appointment of Ms. Ruby Ritolia as CFO and KMP of the Company effective from August 21, 2023.
27-Jul-2023	10-Aug-2023	Quarterly Results	Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve and take on record the Unaudited Financial Results for the quarter ended June 30 2023. Further to our intimation dated July 27, 2023, we wish to inform you that, the Board of Directors of the Company ('Board'), at their meeting held on this day, August 10, 2023, inter alia, has considered and approved the following agenda: 1. Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2023, together with the Limited Review Report thereon; 2. Issue and allotment of 56,550 (Fifty-Six Thousand Five Hundred Fifty) equity shares of the Company of INR 10 each, upon exercise of Employee Stock Options in accordance with the existing Employee Stock Option Schemes of the Company. Unaudited Financial Results (standalone and consolidated) of the Company for the quarter ended June 30, 2023, together with Limited Review Report thereon; issue and allotment of 56,550 equity shares of the Company of INR 10 each, upon exercise of Emploiyee Stock Options in accordance with the exisitng ESOP Scheme of the Company (As Per BSE Announcement dated on 10.08.2023)
12-May-2023	25-May-2023	Accounts	Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2023 inter alia to consider and approve and take on record the Audited Financial Results (both Standalone and Consolidated) of the Company for the quarter and year ended March 31 2023. Board of Directors of the Company, at their meeting held on this day, May 25, 2023, inter alia, has considered and approved Audited Financial Results. (As Per BSE Announcement Dated on 25.05.2023)
28-Mar-2023	27-Mar-2023	Change in Directors	Intimation regarding re-appointment of Dr. B. S. Ajaikumar as Executive Chairman, w.e.f July 01, 2023 and Mrs. Anjali Ajaikumar Rossi as Executive Director w.e.f. April 01, 2023.
25-Jan-2023	09-Feb-2023	Quarterly Results	Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 inter alia to consider and approve Intimation of Meeting of Board of Directors and Earnings call to discuss the Unaudited Financial Results of HealthCare Global Enterprises Limited (the Company). 1. Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2022 together with Limited Review Report thereon; 2. Issue and allotment of 23,125 (Twenty-Three Thousand One Hundred Twenty Five) equity shares of the Company of INR 10 each, upon exercise of Employee Stock Options in accordance with the existing Employee Stock Option Schemes (As Per BSE Announcement Dated on 09/02/2023)
31-Oct-2022	10-Nov-2022	Quarterly Results	Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 inter alia to consider and approve The meeting of the Board of Directors of the Company will be held on Thursday November 10 2022 at the Corporate Office of the Company at No. 3 Tower Block Unity Building Complex Mission Road Bengaluru - 560027 inter-alia to consider approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and half year ended September 30 2022 (Financial Results). Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2022 together with Limited Review Report thereon; Issue and allotment of 12,175 (Twelve Thousand One Hundred Seventy Five) equity shares of the Company of INR 10 each, upon exercise of Employee Stock Options in accordance with the existing Employee Stock Option Schemes. inter-alia to consider, approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2022 ('Financial Results'). (As per BSE Announcement Dated on 10/11/2022)

1 2

LOGIN HERE

Healthcare Global Enterprises Ltd

Board Meeting